Butterfly Network Inc (BFLY) Inventory Turnover Ratio, from third quarter 2026 to third quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
Butterfly Network Inc   (NYSE: BFLY)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

Butterfly Network Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the third quarter 2026, Butterfly Network Inc 's inventory turnover ratio sequentially decreased to 0.62 in the third quarter 2026, unsurprisingly, as the Butterfly Network Inc markets continue to deteriorate, and BFLY's faces growing challenges to bring down its inventories. Butterfly Network Inc 's average inventory processing period in the Sep 30 2026 quarter, has increased to 589 days, from 415 days, in the Jun 30 2026 quarter.

Within Healthcare sector 345 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 673 in the second quarter 2026, to 1880.

BFLY Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Butterfly Network Inc Market Share?

What is Inventory Turnover Ratio?




BFLY Inventory Turnover Ratio (Sep 30 2026)
III. Quarter
(Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
Y / Y Inventory Growth -4.26 % -15.02 % -14.44 % -13.28 % -15.07 %
Y / Y Cost of Sales Growth -64.82 % 16.55 % 14.29 % 10 % 212.5 %
Inventory Turnover Ratio (TTM) 0.62 0.88 0.83 0.78 0.74
BFLY's Total Ranking # 1880 # 673 # 1391 # 787 #
Average inventory processing period 587 413 442 468 495
Seq. Inventory Growth 1.75 % -1.26 % -3.4 % -1.35 % -9.69 %
Seq. Cost of Sales Growth -5.66 % 16.55 % -27.27 % -56 % 212.5 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Laboratories Industry # 14
Healthcare Sector # 346
Overall Market # 1880

Inventory Turnover Ratio Statistics
High Average Low
3.4 1.15 0.37
(Mar 31 2013)   (Sep 30 2023)




Financial Statements
Butterfly Network Inc 's Inventories $ 60 Millions Visit BFLY's Balance sheet
Butterfly Network Inc 's Cost of Revenues TTM $ 37 Millions Visit BFLY's Income Statement
What are BFLY's Sales? Visit BFLY's Sales by Segment

Other Inventory Turnover Ratios
Butterfly Network Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Laboratories Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
BFLY's Inventory Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for BFLY's Competitors
Inventory Turnover Ratio for BFLY's Suppliers
Inventory Turnover Ratio for BFLY's Customers

You may also want to know
BFLY's Sales Growth Rates BFLY's Pe Price to earnings ratio BFLY's Receivables Turnover Ratio BFLY's Stock Quote
BFLY's Net Income Growth Rates BFLY's Ps Price to Sales ratio BFLY's Sales per Employee BFLY's Asset Turnover Ratio
BFLY's Net Margin BFLY's Pb Price to Book ratio BFLY's Financial Strength Ratios BFLY's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2026 Inventories at quarter ending Sep 30 2026
Axsome Therapeutics Inc   1.67 $ 58.422  Millions$ 35  Millions
Insmed Inc  1.66 $ 237.067  Millions$ 143  Millions
Stryker Corp  1.66 $ 9,116.000  Millions$ 5,499  Millions
Bruker Corporation  1.66 $ 1,838.200  Millions$ 1,110  Millions
Bio rad Laboratories Inc   1.64 $ 1,264.000  Millions$ 769  Millions
Pfizer Inc  1.64 $ 16,940.000  Millions$ 10,322  Millions
Integra Lifesciences Holdings Corp  1.62 $ 789.329  Millions$ 486  Millions
Conmed Corporation  1.61 $ 580.951  Millions$ 361  Millions
Axogen inc   1.49 $ 68.923  Millions$ 46  Millions
Aurinia Pharmaceuticals Inc   1.29 $ 30.165  Millions$ 23  Millions
Pulmonx Corporation  1.28 $ 20.450  Millions$ 16  Millions
Alphatec Holdings Inc   1.27 $ 241.341  Millions$ 189  Millions
Si bone inc   1.25 $ 46.999  Millions$ 38  Millions
Bridgebio Pharma Inc   1.24 $ 53.542  Millions$ 43  Millions
Biogen Inc   1.23 $ 2,681.800  Millions$ 2,181  Millions
Kiniksa Pharmaceuticals International Plc  1.21 $ 93.072  Millions$ 77  Millions
Mannkind Corporation  1.16 $ 51.332  Millions$ 44  Millions
Rhythm Pharmaceuticals Inc   1.14 $ 33.056  Millions$ 29  Millions
Penumbra Inc  1.13 $ 499.548  Millions$ 443  Millions
Teleflex Incorporated  1.12 $ 427.166  Millions$ 380  Millions
Acadia Pharmaceuticals Inc   1.12 $ 114.422  Millions$ 102  Millions
Corcept Therapeutics Inc  1.11 $ 14.097  Millions$ 13  Millions
Alkermes Plc   1.10 $ 300.119  Millions$ 273  Millions
Neurocrine Biosciences Inc   1.07 $ 81.200  Millions$ 76  Millions
Emergent Biosolutions Inc   1.07 $ 334.800  Millions$ 314  Millions
Vertex Pharmaceuticals Inc  1.00 $ 1,874.100  Millions$ 1,866  Millions
Amarin Corp Plcuk  0.92 $ 104.502  Millions$ 113  Millions
Eli Lilly And Company  0.89 $ 14,149.700  Millions$ 15,815  Millions
Cerus Corporation  0.87 $ 54.000  Millions$ 62  Millions
Rxsight Inc   0.82 $ 29.342  Millions$ 36  Millions

Date modified: 2026-10-30T13:03:58+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.